| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement of reviewers 2014
|
|
|
2015
|
149 |
1 |
p. 315-319
|
artikel
|
| 2 |
A genetic variant at 12p11 significantly modifies breast cancer risk in a genetically homogenous island population
|
McVeigh, Terri Patricia
|
|
2014
|
149 |
1 |
p. 41-47
|
artikel
|
| 3 |
Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program
|
Castells, Xavier
|
|
2014
|
149 |
1 |
p. 237-244
|
artikel
|
| 4 |
Clinicopathologic characteristics and prognosis of primary squamous cell carcinoma of the breast
|
Liu, Jing
|
|
2014
|
149 |
1 |
p. 133-140
|
artikel
|
| 5 |
Confocal fluorescence microscopy for rapid evaluation of invasive tumor cellularity of inflammatory breast carcinoma core needle biopsies
|
Dobbs, Jessica
|
|
2014
|
149 |
1 |
p. 303-310
|
artikel
|
| 6 |
Effects of the BEAT Cancer physical activity behavior change intervention on physical activity, aerobic fitness, and quality of life in breast cancer survivors: a multicenter randomized controlled trial
|
Rogers, Laura Q.
|
|
2014
|
149 |
1 |
p. 109-119
|
artikel
|
| 7 |
Erratum to: Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer
|
Haynes, Ben P.
|
|
2014
|
149 |
1 |
p. 311
|
artikel
|
| 8 |
Erratum to: Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies
|
Twelves, Chris
|
|
2015
|
149 |
1 |
p. 313
|
artikel
|
| 9 |
Expression profiling of circulating tumor cells in metastatic breast cancer
|
Lang, Julie E.
|
|
2014
|
149 |
1 |
p. 121-131
|
artikel
|
| 10 |
Fulvestrant and male breast cancer: a pooled analysis
|
Zagouri, Flora
|
|
2014
|
149 |
1 |
p. 269-275
|
artikel
|
| 11 |
Geographic access and age-related variation in chemotherapy use in elderly with metastatic breast cancer
|
Wan, Shaowei
|
|
2014
|
149 |
1 |
p. 199-209
|
artikel
|
| 12 |
Greater absolute risk for all subtypes of breast cancer in the US than Malaysia
|
Horne, Hisani N.
|
|
2014
|
149 |
1 |
p. 285-291
|
artikel
|
| 13 |
HDAC inhibition does not induce estrogen receptor in human triple-negative breast cancer cell lines and patient-derived xenografts
|
Cremoux, Patricia de
|
|
2014
|
149 |
1 |
p. 81-89
|
artikel
|
| 14 |
HER2-family signalling mechanisms, clinical implications and targeting in breast cancer
|
Elster, N.
|
|
2014
|
149 |
1 |
p. 5-15
|
artikel
|
| 15 |
Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses’ Health Studies
|
Rice, Megan S.
|
|
2014
|
149 |
1 |
p. 245-253
|
artikel
|
| 16 |
Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry
|
Rosenthal, Eric
|
|
2014
|
149 |
1 |
p. 223-227
|
artikel
|
| 17 |
Incidence of breast cancer in a cohort of 5,135 transgender veterans
|
Brown, George R.
|
|
2014
|
149 |
1 |
p. 191-198
|
artikel
|
| 18 |
Inherited predisposition to breast cancer among African American women
|
Churpek, Jane E.
|
|
2014
|
149 |
1 |
p. 31-39
|
artikel
|
| 19 |
In vivo anti-metastatic effects of uPAR retargeted measles virus in syngeneic and xenograft models of mammary cancer
|
Jing, Yuqi
|
|
2014
|
149 |
1 |
p. 99-108
|
artikel
|
| 20 |
No effect of scalp cooling on survival among women with breast cancer
|
Lemieux, J.
|
|
2014
|
149 |
1 |
p. 263-268
|
artikel
|
| 21 |
Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production
|
Bowers, Laura W.
|
|
2014
|
149 |
1 |
p. 49-57
|
artikel
|
| 22 |
Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer
|
Tolaney, Sara
|
|
2014
|
149 |
1 |
p. 151-161
|
artikel
|
| 23 |
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer
|
Lück, Hans-Joachim
|
|
2014
|
149 |
1 |
p. 141-149
|
artikel
|
| 24 |
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer
|
Clemens, Michael R.
|
|
2014
|
149 |
1 |
p. 171-179
|
artikel
|
| 25 |
Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis
|
Strasser-Weippl, Kathrin
|
|
2014
|
149 |
1 |
p. 255-261
|
artikel
|
| 26 |
Prognostic factors of HER2-positive breast cancer patients who develop brain metastasis: a multicenter retrospective analysis
|
Hayashi, Naoki
|
|
2014
|
149 |
1 |
p. 277-284
|
artikel
|
| 27 |
Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis
|
Dowsett, Mitch
|
|
2014
|
149 |
1 |
p. 1-4
|
artikel
|
| 28 |
Reduced risk of axillary lymphatic spread in triple-negative breast cancer
|
Holm-Rasmussen, Emil Villiam
|
|
2014
|
149 |
1 |
p. 229-236
|
artikel
|
| 29 |
Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors
|
Yeh, Elizabeth S.
|
|
2014
|
149 |
1 |
p. 91-98
|
artikel
|
| 30 |
Single-nucleotide polymorphisms in DNA bypass polymerase genes and association with breast cancer and breast cancer subtypes among African Americans and Whites
|
Family, Leila
|
|
2014
|
149 |
1 |
p. 181-190
|
artikel
|
| 31 |
Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer
|
Alshaker, Heba
|
|
2014
|
149 |
1 |
p. 59-67
|
artikel
|
| 32 |
Stearidonic acid-enriched flax oil reduces the growth of human breast cancer in vitro and in vivo
|
Subedi, K.
|
|
2014
|
149 |
1 |
p. 17-29
|
artikel
|
| 33 |
The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer
|
Bean, Jennifer R.
|
|
2014
|
149 |
1 |
p. 69-79
|
artikel
|
| 34 |
Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implications
|
Jerzak, Katarzyna J.
|
|
2014
|
149 |
1 |
p. 293-301
|
artikel
|
| 35 |
Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50
|
Winch, Caleb J.
|
|
2014
|
149 |
1 |
p. 211-221
|
artikel
|
| 36 |
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II study
|
Tan, A. R.
|
|
2014
|
149 |
1 |
p. 163-169
|
artikel
|
Tijdschrift beschrijving